This inventor holds 3 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignees: Fabrus, Inc., Taurus Biosciences, LLC. Active years: 2015-2020.
Company Filing History:
Years Active: 2015-2020
Title: Tyson Chase: Innovator in Antibody Technology
Introduction
Tyson Chase is a prominent inventor based in San Diego, CA, known for his significant contributions to the field of antibody technology. With a total of 3 patents, he has made remarkable advancements that have the potential to impact therapeutic applications.
Latest Patents
One of Tyson's latest patents is titled "Combinatorial antibody libraries and uses thereof." This patent provides methods for creating a combinatorial antibody library from human germline segments. It includes libraries of nucleic acid molecules compiled from germline segments encoding VL chains and libraries of nucleic acid molecules encoding VH chains, resulting in addressable antibody libraries. Additionally, the patent outlines methods for screening these antibody libraries against target protein antigens, along with the identified or selected antibodies. Another notable patent is "Anti-DLL4 antibodies and uses thereof," which describes anti-DLL4 antibodies and their therapeutic applications in diseases or disorders associated with DLL4.
Career Highlights
Throughout his career, Tyson has worked with notable companies such as Fabrus, Inc. and Taurus Biosciences, LLC. His work has been instrumental in advancing the understanding and application of antibody technologies.
Collaborations
Tyson has collaborated with esteemed colleagues, including Vaughn V Smider and Helen Hongyuan Mao, further enhancing the innovative work in his field.
Conclusion
Tyson Chase's contributions to antibody technology through his patents and collaborations highlight his role as a key innovator in the field. His work continues to pave the way for advancements in therapeutic applications.